ArticleFukushima journal of medical science2026
Evaluating preoperative gemcitabine-based chemoradiation for resectable and borderline resectable pancreatic cancer: a phase 1 study.
Naoya Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.